Octreotide [oktreotid]
- Terms
-
oktreotid acetát
Sandostatin
syntetický derivát somatostatinu
synteticky vyrobený somatostatin
-
Compound 201-995
Octreotide Acetate
Octreotide Acetate Salt
SAN 201-995
Sandostatin
Sandostatine
Sandoz 201-995
SM 201-995
SMS 201-995
A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula.
- DUI
- D015282 MeSH Browser
- CUI
- M0023526
- CAS
- L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2-7)-disulfide, (R-(R*,R*))-
- Previous indexing
- Antineoplastic Agents (1982-1988); Somatostatin/analogs & derivatives (1982-1988)
- History note
- 89
- Public note
- 89
Allowable subheadings
- AD
- administration & dosage 61
- AE
- adverse effects 16
- AG
- agonists
- AA
- analogs & derivatives 13
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry 4
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 10
- PD
- pharmacology 38
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 88
- TO
- toxicity
- UR
- urine
octreotide-conjugated paclitaxel Chemical MeSH Browser